Matsugi; Takeshi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Matsugi; Takeshi.The latest application filed is for "novel indazole derivative or salt thereof and production intermediate thereof, and antioxidant using same, and use of indazole derivative or salt thereof".

Company Profile

0.8.14

Matsugi; Takeshi - Osaka N/A JP
Matsugi; Takeshi - Osaka-shi JP
Matsugi; Takeshi - Ikoma JP
MATSUGI; Takeshi - Ikoma-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indazole derivative or salt thereof and production intermediate thereof, and antioxidant using same, and use of indazole derivative or salt thereof Grant 8,816,092 - Hagihara , et al. August 26, 2	2014-08-26
Novel Indazole Derivative Or Salt Thereof And Production Intermediate Thereof, And Antioxidant Using Same, And Use Of Indazole Derivative Or Salt Thereof App 20130102787 - Hagihara; Masahiko ; et al.	2013-04-25
Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient Grant 8,252,945 - Seike , et al. August 28, 2	2012-08-28
Methods for treating a disease in which Rho kinase is involved Grant 8,232,308 - Hagihara , et al. July 31, 2	2012-07-31
Indazole derivative having spiro ring structure in side chain Grant 8,227,480 - Hagihara , et al. July 24, 2	2012-07-24
THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDIN App 20120040994 - NAKAJIMA; Tadashi ; et al.	2012-02-16
Therapeutic agent for glaucoma comprising rho kinase inhibitor and - blocker App 20110263638 - Hatano; Masakazu ; et al.	2011-10-27
Remedy for glaucoma comprising Rho kinase inhibitor and .beta.-blocker Grant 7,972,612 - Hatano , et al. July 5, 2	2011-07-05
Methods for treating a disease in which Rho kinase is involved App 20110039891 - Hagihara; Masahiko ; et al.	2011-02-17
Methods for treating a disease in which Rho kinase is involved Grant 7,855,222 - Hagihara , et al. December 21, 2	2010-12-21
Therapeutic agent for glaucoma comprising Rho Kinhase inhibitor and prostaglandin App 20100063060 - Nakajima; Tadashi ; et al.	2010-03-11
Methods for treating glaucoma App 20100041671 - Nakajima; Tadashi ; et al.	2010-02-18
Methods for treating a disease in which Rho kinase is involved App 20090264468 - Hagihara; Masahiko ; et al.	2009-10-22
Indazole derivatives Grant 7,563,906 - Hagihara , et al. July 21, 2	2009-07-21
Novel indazole derivative having spiro ring structure in side chain App 20090170887 - Hagihara; Masahiko ; et al.	2009-07-02
Protective Agent for Retinal Neuronal Cell Comprising Indazole Derivative as Active Ingredient App 20090012123 - Seike; Hisayuki ; et al.	2009-01-08
Novel indazole derivatives App 20070129404 - Hagihara; Masahiko ; et al.	2007-06-07
Remedy for glaucoma comprising rho kinase inhibitor and beta-blocker App 20060052367 - Hatano; Masakazu ; et al.	2006-03-09
Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins App 20050245509 - Nakajima, Tadashi ; et al.	2005-11-03
Remedy for glaucoma comprising as the active ingredient compound having p13 kinase inhibitory effect App 20040242545 - Otsuka, Yoshihisa ; et al.	2004-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.